Ryanto G, Suraya R, Nagano T
Pathogens. 2025; 14(1).
PMID: 39861052
PMC: 11768135.
DOI: 10.3390/pathogens14010091.
Sen Chaudhuri A, Sun J
Chin Med J Pulm Crit Care Med. 2025; 2(4):214-223.
PMID: 39834580
PMC: 11742555.
DOI: 10.1016/j.pccm.2024.11.006.
Claus M, Freitag M, Ewald M, Rodon L, Deicher F, Watzl C
Arthritis Res Ther. 2024; 26(1):211.
PMID: 39673062
PMC: 11639114.
DOI: 10.1186/s13075-024-03451-1.
He D, Shannon C, Hirota J, Ask K, Ryerson C, Tebbutt S
PLoS One. 2024; 19(12):e0314876.
PMID: 39625896
PMC: 11614250.
DOI: 10.1371/journal.pone.0314876.
Fu C, Tian X, Wu S, Chu X, Cheng Y, Wu X
Front Genet. 2024; 15:1447296.
PMID: 39346776
PMC: 11427275.
DOI: 10.3389/fgene.2024.1447296.
Cell-cell interactions and communication dynamics in lung fibrosis.
Xie T, Liang J, Stripp B, Noble P
Chin Med J Pulm Crit Care Med. 2024; 2(2):63-71.
PMID: 39169931
PMC: 11332853.
DOI: 10.1016/j.pccm.2024.04.001.
Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities.
Hernandez-Gonzalez F, Pietrocola F, Cameli P, Bargagli E, Prieto-Gonzalez S, Cruz T
Int J Mol Sci. 2024; 25(14).
PMID: 39062798
PMC: 11276754.
DOI: 10.3390/ijms25147554.
LEF1 isoforms regulate cellular senescence and aging.
Jia M, Sayed K, Kapetanaki M, Dion W, Rosas L, Irfan S
Aging Cell. 2023; 22(12):e14024.
PMID: 37961030
PMC: 10726832.
DOI: 10.1111/acel.14024.
Lung immune signatures define two groups of end-stage IPF patients.
Cruz T, Mendoza N, Casas-Recasens S, Noell G, Hernandez-Gonzalez F, Frino-Garcia A
Respir Res. 2023; 24(1):236.
PMID: 37770891
PMC: 10540496.
DOI: 10.1186/s12931-023-02546-8.
Impact of enzymatic digestion on single cell suspension yield from peripheral human lung tissue.
Bondonese A, Craig A, Fan L, Valenzi E, Bain W, Lafyatis R
Cytometry A. 2023; 103(10):777-785.
PMID: 37449375
PMC: 10592386.
DOI: 10.1002/cyto.a.24777.
Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs.
Padilla C, Valenzi E, Tabib T, Nazari B, Sembrat J, Rojas M
Rheumatology (Oxford). 2023; 63(3):837-845.
PMID: 37310903
PMC: 10907815.
DOI: 10.1093/rheumatology/kead273.
Potential of resveratrol in the treatment of interstitial lung disease.
Huo R, Huang X, Yang Y, Yang Y, Lin J
Front Pharmacol. 2023; 14:1139460.
PMID: 37089962
PMC: 10117935.
DOI: 10.3389/fphar.2023.1139460.
A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis.
Guo R, Zhou Y, Lin F, Li M, Tan C, Xu B
Front Pharmacol. 2022; 13:981604.
PMID: 36147332
PMC: 9489050.
DOI: 10.3389/fphar.2022.981604.
Stem cells, cell therapies, and bioengineering in lung biology and disease 2021.
Ikonomou L, Magnusson M, Dries R, Herzog E, Hynds R, Borok Z
Am J Physiol Lung Cell Mol Physiol. 2022; 323(3):L341-L354.
PMID: 35762622
PMC: 9484991.
DOI: 10.1152/ajplung.00113.2022.
Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes.
Zheng J, Dong H, Zhang T, Ning J, Xu Y, Cai C
Front Genet. 2022; 13:865052.
PMID: 35559024
PMC: 9086533.
DOI: 10.3389/fgene.2022.865052.
